Home 2021

Archives

Mitigating melanoma

Early detection and intervention is key for higher survival rates. Takeaways: Late identification and recognition of melanoma lead to worsening health outcomes. Nursing patient education...
radiation dermatitis

Understanding radiation dermatitis

According to the National Cancer Institute, an estimated 1.6 million new cases of cancer will have been diagnosed in the United States in 2015....
parent

From our readers: When your parent is the patient

It’s not easy when your parent is the patient. In my 10 years of being a registered nurse, I have learned a lot, seen...
Cancer survivorship

Long-term cancer survivorship nurse practitioner care model promotes patient quality of life

It’s not uncommon for cancer patients to say they classify themselves as a cancer survivor by having lived at least 5 years past the...

Brushing up on mouth care for cancer patients with mucositis

Chemotherapy and radiation used to treat head and neck cancers, as well as high-dose chemo­therapy given to stem-cell transplant patients, can damage the mucosa...

Breast cancer care gets personal

Learning objectives 1. State how breast cancer is diagnosed and evaluated. 2. Identify the implications of genetics for patients with breast cancer. 3. Discuss targeted therapy for...
Tripping over the welcome mat: Why new nurses don’t stay and what the evidence says we can do about it

When good people make hard choices…*

Leah Curtin discusses the difficulty of making choices in health care and includes a challenging situation she experienced as a student.

FDA approves drug for treating rare type of non-Hodgkin lymphoma

On July 3, the U.S. Food and Drug Administration (FDA) approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma, a rare...

FDA approves new indication for imaging agent

On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent...

FDA approves Zykadia for NSCLC

On April 29, the U.S. Food and Drug Administration (FDA) approved Zykadia for patients with a certain type of late-stage non-small cell lung cancer...

FDA approves Impavido to treat leishmaniasis

On March 19, the U.S. Food and Drug Administration (FDA) approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Read more.

FDA approves Imbruvica to treat chronic lymphocytic leukemia

On Feb. 13, the U.S. Food and Drug Administration (FDA) expanded the approved use of Imbruvica (ibrutinib) for chronic lymphocytic leukemia patients who have...

Study: Radiation therapy skin reactions may be preventable

Severe skin reactions during radiation therapy could be prevented by applying a thin transparent silicone dressing to the skin from the first day of...

Study: Melanoma increases among middle-aged adults

A study in Mayo Clinic Proceedings reports that the incidence of cutaneous melanoma among middle-aged adults (40 to 60 years) has increased nearly eightfold...

From our readers: One nurse’s journey into patienthood

As I lay on the table staring up at the ceiling tiles and waited for my biopsy to begin, I suddenly became keenly aware...

FDA approves Mekinist in combination with Tafinlar for advanced melanoma

On Jan. 10, the U.S. Food and Drug Administration (FDA) announced it had approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to treat patients...

Study: Incidence of mental disorders in mid-life, older adulthood may be underestimated

A study published in JAMA Psychiatry has found that common methods of assessing mental or physical disorders may consistently underestimate the prevalence of mental...

Only 1 in 6 have discussed their alcohol use with a health professional

According to a report from the Centers for Disease Control and Prevention (CDC) only 1 in 6 adults have discussed their alcohol use with...
Guiding your patients through menopause

Guiding your patients through menopause

The more you know about menopause, the more you can help patients understand and cope with symptoms.

FDA approves Gazyva for chronic lymphocytic leukemia

On Nov. 1, the U.S. Food and Drug Administration (FDA) approved Gazyva (obinutuzumab) for use in combination with chlorambucil to treat patients with previously...

FDA approves first generic capecitabine to treat breast and colorectal cancers

On Sept. 16, the U.S. Food and Drug Administration (FDA) approved the first generic version of Xeloda (capecitabine), used to treat metastatic breast and...

Study: Regular colonoscopy screening could prevent 40% of colorectal cancers

Regular colonoscopy screening could prevent 40% of colorectal cancers, according to a study in the New England Medical Journal that followed 88,902 participants from...

Study: Tamoxifen reduces future risk of breast cancer in women with genetic predisposition who...

A study, published by the Journal of Clinical Oncology, of about 2,500 women has found that those who have inherited mutations in BRCA1 or...

How to safely enjoy the sun

Protect yourself and your patients from harmful sun effects.

Radiation therapy 101

More than half of cancer patients get radiation therapy. This article gives a basic overview of this potentially life-saving treatment, discusses nursing interventions for radiation patients, and tells you what you need to know to provide education and emotional support to patients and their families.

Study: HPV increases risk of esophageal cancer

A meta-analysis published by PLOSOne found that human papillomavirus (HPV) triples the risk for esophageal squamous cell carcinoma. Read more
Managing atrioventricular blocks

Polymyalgia rheumatica: A possible cause of pericardial effusion

Suspect polymyalgia in patients who continue to decline after treatment for pericardial effusion.
oncologist_oncology_cancer_nurse

From our readers: On being an oncology nurse, or humble pie by the slice

I came to oncology nursing in 1984 through what I perceived as bad luck; my goal was to get out of the field ASAP....

Study: Shortages of cancer drugs associated with medication errors and higher

A study in the American Journal of Health-System Pharmacy reports a survey of oncology pharmacists in the United States found that shortages of oncology...

Hospital volume associated with better survival in patients with head and neck cancer

“Hospital volume is associated with survival but not multimodality therapy in Medicare patients with advanced head and neck cancer,” published in Cancer, found that...

FDA approves Pomalyst for advanced multiple myeloma

On Feb. 8, 2013, the U.S. Food and Drug Administration (FDA) approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease has progressed...

FDA expands Zytiga’s use for late-stage breast cancer

On Dec. 10, the U.S. Food and Drug Administration expanded the approved use of Zytiga (abiraterone acetate) to treat men with metastatic castration-resistant prostate...

Study: Delaying childbirth may reduce risk of aggressive form of breast cancer

Younger women who wait at least 15 years after their first menstrual period to give birth to their first child may reduce their risk...

FDA approves Synribo for chronic myelogenous leukemia

On Oct. 26, the U.S. Food and Drug Administration (FDA) approved Synribo (omacetaxine mepesuccinate) for the treatment of adults with chronic myelogenous leukemia. Synribo...

Study: Online prostate cancer information may be hard for patients to understand

Although experts recommend that patient-education materials be written at the fourth-through-sixth grade level, a study published online by the Journal of Urology found that...

Putting Evidence Into Practice: Cognitive impairment

The latest in a series of articles on managing cancer-related symptoms from the Oncology Nursing Society.

Most Recent Content

For Nurse Practitioners

Women suffering from a migraine

Quiz: Migraines and Hormones

Women are 2 to 3 times more likely than men to have migraines.  Decades ago, these were attributed to women’s inability to cope with...